← Back to Search

Behavioral Intervention

Digital Media Campaign for Tobacco Use Prevention (DMCC Trial)

N/A
Recruiting
Research Sponsored by George Washington University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Young adults age 18-24 who are members of the Ipsos/Knowledge Panel
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up ad awareness outcome (aim 1): by the end of year 1, vaping & smoking outcome (aim 2): by the end of year 5
Awards & highlights
No Placebo-Only Group

Summary

This trial will examine the effects of online anti-tobacco messages on young people's attitudes, beliefs, and behaviors related to tobacco use.

Who is the study for?
This trial is for young adults aged 18-24 who are part of the Ipsos/Knowledge Panel. It's designed to evaluate if digital ads can influence anti-tobacco attitudes and behaviors. People outside this age group or not in the panel cannot participate.
What is being tested?
The study tests the impact of different levels of exposure to anti-vaping and anti-smoking digital advertising on youth and young adult attitudes, beliefs, or actions against tobacco use through online experiments and field evaluations.
What are the potential side effects?
Since this trial involves exposure to digital media campaigns rather than medical treatments, traditional side effects are not applicable. However, participants may experience changes in perception towards tobacco use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am aged 18-24 and a member of the Ipsos/Knowledge Panel.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~ad awareness outcome (aim 1): by the end of year 1, vaping & smoking outcome (aim 2): by the end of year 5
This trial's timeline: 3 weeks for screening, Varies for treatment, and ad awareness outcome (aim 1): by the end of year 1, vaping & smoking outcome (aim 2): by the end of year 5 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
30-day use of electronic cigarettes (vaping)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Digital interventionExperimental Treatment1 Intervention
Participants will be randomized to receive variable levels of exposure (including no exposure control) of digital anti-vaping and anti-smoking messages. We will evaluate the effects of experimental condition and exposure on outcomes (tobacco product use).
Group II: ControlActive Control1 Intervention
No exposure control condition

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,819 Previous Clinical Trials
8,159,596 Total Patients Enrolled
9 Trials studying Tobacco Use
5,904 Patients Enrolled for Tobacco Use
George Washington UniversityLead Sponsor
254 Previous Clinical Trials
463,795 Total Patients Enrolled
2 Trials studying Tobacco Use
300 Patients Enrolled for Tobacco Use

Media Library

Anti-vaping and anti-smoking digital advertising (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04867668 — N/A
Tobacco Use Research Study Groups: Digital intervention, Control
Tobacco Use Clinical Trial 2023: Anti-vaping and anti-smoking digital advertising Highlights & Side Effects. Trial Name: NCT04867668 — N/A
Anti-vaping and anti-smoking digital advertising (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04867668 — N/A
~275 spots leftby May 2025